Skip to content

Book value per share at other companies

MBX Biosciences, Inc. logo
MBX Biosciences, Inc.MBX
$9.40+33.4%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$4.34-42.5%
Beam Therapeutics logo
Beam TherapeuticsBEAM
$11.28-12.2%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$12.30-8.7%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$18.87-26.1%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$1.81+502%

Other financials

Income statement

See full
Revenue-
Gross profit-
Operating income-$43.8M-15.8%
Net income-$41.3M-15.0%
EPS (diluted)-$0.37+11.9%

Balance sheet

See full
Cash & equivalents$229.1M+283%
Total debt$5.6M+307%
Total equity$273.2M+35.6%
Total assets$293.6M+33.7%

Cash flow

See full
Operating cash flow-$36.9M+7.4%
CapEx$86.0K+330%
Free cash flow-$28.0M+52.6%

Valuation

See full
Market cap$1.82B+390%
Enterprise value$1.6B+414%

Profitability

See full
Gross margin100%+6.9pp
Operating margin-47,349.8%-47,409pp
Net margin-45,096.2%-45,152pp
FCF margin-39,826.7%-39,847pp

Returns & leverage

See full
Return on equity-63.3%-12.2pp
Debt / equity0.0×
Current ratio17.9×+5.8×

Where this comes from

Calculated from Amylyx Pharmaceuticals, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Amylyx Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amylyx Pharmaceuticals, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amylyx Pharmaceuticals, Inc.'s book value per share?
Amylyx Pharmaceuticals, Inc. (AMLX) reported book value per share of $2.47 in Q1 2026.
How has Amylyx Pharmaceuticals, Inc.'s book value per share changed year-over-year?
Amylyx Pharmaceuticals, Inc.'s book value per share increased by 5.1% year-over-year, from $2.35 to $2.47.
What is the long-term trend for Amylyx Pharmaceuticals, Inc.'s book value per share?
Over 4 years (2021 to 2025), Amylyx Pharmaceuticals, Inc.'s book value per share has grown at a -38.8% compound annual growth rate (CAGR), from -$22.95 to $3.23.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.